USP24 promotes hepatocellular carcinoma tumorigenesis through deubiquitinating and stabilizing TRAF2
Open Access
- 9 August 2024
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 229, 116473
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Province Science and Technology Department (2020C03008)
- Science and Technology Program of Zhejiang Province
- Hubei Provincial Central Guidance Local Science and Technology Development Project
- Zhejiang Province Natural Science Foundation (LTGY23H160032)
This publication has 35 references indexed in Scilit:
- Related cellular signaling and consequent pathophysiological outcomes of ubiquitin specific protease 24Life Sciences, 2024
- NCI677397 targeting USP24‐mediated induction of lipid peroxidation induces ferroptosis in drug‐resistant cancer cellsMolecular Oncology, 2023
- FGF19/FGFR4 signaling contributes to hepatocellular carcinoma survival and immune escape by regulating IGF2BP1-mediated expression of PD-L1Biomedicine & Pharmacotherapy, 2023
- Elevated FBXW10 drives hepatocellular carcinoma tumorigenesis via AR-VRK2 phosphorylation-dependent GAPDH ubiquitination in male transgenic miceCell Reports, 2023
- Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkersCancer and Metastasis Reviews, 2023
- ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 AxisCancer Cell, 2020
- TRAF2 multitasking in TNF receptor-induced signaling to NF-κB, MAP kinases and cell deathBiochemical Pharmacology, 2016
- The Deubiquitinating Enzyme USP24 Is a Regulator of the UV Damage ResponseCell Reports, 2015
- Growth differentiation factor 15 stimulates rapamycin-sensitive ovarian cancer cell growth and invasionBiochemical Pharmacology, 2013
- Hepatocellular carcinomaThe Lancet, 2003